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1 INTRODUCTION
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Over 45 000 new cases of rectal and anal cancer (RACa) are diagnosed yearly in the United
States.1 Treatment typically requires a combination of surgery, chemotherapy, and radiation
and may result in persistent bowel dysfunction.2,3 Bowel symptoms include increased
frequency and urgency, incontinence, leakage/soilage, abnormal sensation or painful bowel
movements, evacuation difficulties, and diarrhea. Deterioration of bowel functioning has
been described with concurrent disruptions in daily routines, sexual difficulties as well as
lowered emotional well-being and quality of life (QOL).4,5 Symptoms are frequent and can
be severe, especially in the first year after treatment but may persist beyond that as well.2,3
Five years postsurgery, 5% to 63% of patients persistent bowel problems.6 In colorectal
cancer, greater severity of bowel symptoms was related to increased depression and anxiety.6
Understanding the mechanism by which bowel dysfunction affects psychological variables is
an important step to improving RACa survivorship.
The objective of this study was to examine the relationship among bowel dysfunction and
the psychosocial variables of social functioning, depression, and anxiety in a sample of
RACa survivors. It was hypothesized that greater severity of bowel symptoms would lead to
increased depression and anxiety and that disruptions in social functioning would mediate
the relationship between bowel dysfunction and increased depression and anxiety. Given the
chronic nature of these side effects and associated impairments in daily functioning and
QOL, findings may have important implications for posttreatment survivorship care.
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2 METHODS
As part of a sexual health intervention study, participants completed a baseline
(preintervention) assessment questionnaire.7 Institutional Review Board approval was
obtained (#08-073).
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2.1 Participants
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Participants were posttreatment for stages I to III rectal or anal cancer with no evidence of
disease, at least 21 years old, and proficient in English. Eligibility criteria also required
female participants to have low to moderate sexual satisfaction and male participants to have
difficulty with erectile dysfunction, bother related to this difficulty, and to be married or in a
committed relationship. All participants gave informed consent.
2.2 Measures
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The European Organization for Research and Treatment of Cancer Core Quality of Life
Questionnaire8 and Colorectal Cancer-Specific Module9 The Diarrhea (1 item) and Social
Functioning (2 items) sub-scales were included in this analysis. Responses were on a 4-point
scale from “Not at all” to “Very much.” Higher scores indicate greater severity of diarrhea
and better social function.
The Brief Symptom Inventory (BSI)10 Depression and Anxiety sub-scales were used in this
analysis. Respondents rated how much discomfort problems have caused them in the past
month on a 5-point scale (“Not at all” to “Extremely”). Higher scores indicate greater
depressive and anxiety symptoms.
2.3 Analyses
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Descriptive statistics characterized the data and Pearson’s correlation tested bivariate
relations. Following standard guidelines for establishing mediation,11 regression analyses
tested whether disruptions in social functioning explained relations between diarrhea and
depression and anxiety (Figure S1), based on the literature and hypotheses regarding the
psychosocial effects of bowel dysfunction. Tests of mediation were conducted separately for
depression and anxiety.11 Models specified diarrhea as the predictor, social function as the
mediator, and depression and anxiety as outcome variables (separate analyses), controlling
for a priori covariates (age, gender, disease type, time since treatment, and stoma; Table 3).11

3 RESULTS
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Descriptive data for the 144 subjects are provided in Table 1. Participants (51% male) were
on average 56 years old (SD = 10.3) and 4.6 (SD = 3.3) years posttreatment. Clinically
significant levels of depression and anxiety were reported by 18% and 19% of participants,
respectively.10 Diarrhea was endorsed by 38% of participants. There were no differences
based on gender (male vs female), disease type (rectal vs anal cancer), or stoma status
(stoma vs no stoma) in reports of diarrhea, social function, or levels of distress (P’s > .05).
At marginal significance, women reported higher levels of social function than men (M =
80.5, SD = 25.5 and M = 72.2, SD = 28.8, respectively, P < .10). Greater severity of diarrhea
was associated with worse social function (r = −0.52) and higher levels of depression (r =
0.36) and anxiety (r = 0.29; bivariate relations included in Table S1).
3.1 Depression
In separate models, diarrhea was significantly associated with social function (β = −.53) and
depression (β = .39). Social function was associated with depression (β = −.57). In the final
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test of mediation, the relation between diarrhea and depression was no longer significant (β
= .13) when social function was included in the model (β = −.50; Table 2; Figure S1a). The
hypothesized mediating role of social function to explain the effect of diarrhea on depression
was supported. Thirty-two percent of the variance in depression was accounted for in the
final model, and no other covariates were related to depression (P’s > .05).
3.2 Anxiety
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The same procedure was done with anxiety as the outcome variable. In separate models,
diarrhea was significantly related to social function (β = −.53) and anxiety (β = .32); and
social function was related to anxiety (β = −.47). When social function was included in the
model, the effect of diarrhea on anxiety was no longer significant (β = .09; Table 2; Figure
S1b). Social function remained a significant predictor of anxiety (β = −.43), supporting the
hypothesized role of mediation. The final model accounted for 28% of the variance in
anxiety. At marginally significant levels, males reported less anxiety than females and longer
time since treatment was associated with greater anxiety.

4 DISCUSSION
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In this cross-sectional study of 144 RACa survivors who were on average 4.6 years
posttreatment, a meaningful percentage reported anxiety and depressive symptoms. While
the percent of those reporting anxiety (19%) is considered high and suggestive of significant
psychological distress, the percent of patients reporting depressive symptoms (18%) is also
strikingly high. Taken together, data present a strong case that RACa survivors should be
followed for psychological distress and referred to psychological services if distress levels
are high. Psychological distress was related to, and possibly caused by, difficulty with
diarrhea reported by a large percentage of survivors (38%). The significant impact bowel
side effects can have on the social functioning of these patients is also evident. This is
congruent with our clinical work as many patients report withdrawing from social activities
for fear that they will have an embarrassing bowel accident. The mediation analysis supports
the hypothesized role of social activities as an important mechanism in the relationship
among bowel problems and increased anxiety and depression.
4.1 Clinical implications
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These data signify the importance of targeting distressing and disruptive side effects of
RACa treatment to help maintain or improve engagement in social activities and to reduce
anxiety and depression posttreatment. Consistent with the literature,3 survivors in this study
were on average more than 4 years posttreatment, demonstrating the persistent and
refractory nature of side effects. Rectal and anal cancer treatment has shown excellent
efficacy in treating the disease. Unfortunately, treatment leaves a large percentage of patients
with persistent bowel difficulties that can impact their life in many ways including reduction
of social activities. Surgeons and oncologists who treat RACa continue to test treatments to
help address the bowel side effects of these patients. Until they are successful, however, the
primary mechanism for helping these patients may be through psychosocial interventions to
assist them in coping with distressing and disruptive side effects and better management of
their lives posttreatment.
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Future work in this area should focus on the development of psychosocial interventions to
help RACa survivors build strategies to deal with these persistent symptoms. Fostering
social interactions and engagement should be an important piece to these interventions,
particularly given the prolonged nature of symptom experiences. Focusing on problemsolving strategies to help patient feel more confidence managing their symptoms, engaging
with friends and family, and maintaining social activities could be useful. Teaching patients
to manage their worries or fears related to bowel symptom occurrence and reduce avoidance
of important activities may also be helpful. A number of therapeutic approaches such as
cognitive-behavioral therapy, problem-solving therapy, and acceptance and commitment
therapy may be specifically useful for these patients and their concerns. Given the data
presented here, the development of these types of interventions should be considered a high
priority. Appropriate symptom management, combined with strategies to address worries or
fears related to symptom occurrence, may help to mitigate or avoid the social and QOL
deficits associated with long-term bowel dysfunction.
Strengths of this study include a relatively large sample size of RACa patients and the
assessment of anxiety and depression, which is unique in the RACa literature. Nevertheless,
the study also has limitations. The cross-sectional design precludes causal inferences.
Second, more comprehensive scales exist for both bowel function and social function and
should be used in future studies. Diversity (eg, ethnicity) of the sample was limited and a
more diverse sample may demonstrate variability in coping with these side effects. Lastly,
the sample included a limited number of stoma patients, and this is a subgroup of survivors
with potentially different needs when designing psychosocial interventions. Future work
should focus on psychosocial interventions to help survivors cope the persistent bowel
symptoms.
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Key points
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•

The percentage of rectal and anal cancer survivors reporting clinically
significant anxiety (19%) and depressive symptoms (18%) was high,
presenting a strong case that patients should be followed for psychological
distress after treatment.

•

Psychological distress was found to be related to difficulty with diarrhea, and
reduction in social activities was found to mediate (account for) this
relationship.

•

(Alternative: The results suggest that chronic diarrhea is related to a reduction
in social activities, which then relate to higher levels of depression and
anxiety.)

•

These data signify the importance of targeting distressing and disruptive side
effects of rectal and anal cancer treatment to help maintain or improve
engagement in social activities and to reduce anxiety and depression in these
survivors.

•

Surgeons and oncologists who treat rectal and anal cancer continue to test
treatments to help address the bowel side effects of these patients; however,
until they are successful, the primary mechanism for helping patients may be
through psychosocial interventions to assist them in coping with side effects
and better management of their lives post-treatment.

•

Future work in this area should focus on the development of psychosocial
interventions to help survivors build strategies to deal with these persistent
symptoms and to maintain and foster social interactions and engagement.
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TABLE 1

Author Manuscript

Descriptive characteristics of the study sample (N = 144)
Demographics & Clinical Information

M, SD

Age (mean, SD; y)

56, 10.3

Male

%

51

Race
White

81

Hispanic ethnicity

7

Employed

65

Annual income
Less than $50 000

24

Partnered

71

Author Manuscript

Time since tx (mean, SD; y)

4.6, 3.3

Cancer type
Rectal cancer

76

Anal cancer

20

Treatment
Radiation/chemo

71

Surgery

73

Permanent stoma

15

Main variables
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M, SD

Range

%

Diarrheaa

20.1, 29.3

0–100

38

Social Functionb

75.6, 27.3

0–100

Disruptions to family life

43

Disruptions to social activities

52

Psychological Distressc

a

Depressive symptoms

0.58, 0.71

0–3

18

Anxiety symptoms

0.59, 0.59

0–2.7

19

Higher scores indicate worse diarrhea; percentages refer to those who answered “A little,” “Quite a bit,” or “Very much.”

b

Higher scores indicate better social function; percentages refer to those who answered “A little,” “Quite a bit,” or “Very much.”

c
Higher scores indicate greater severity of depressive and anxiety symptoms; percentages refer to validated case rule indicating clinical significance
(above the 90th percentile).
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.01
−.17
−.01
.003

Years since treatment

Stoma (0 = no)

Social function

Diarrhea

.002

.002

.15

.02

.14

.11

.01

1.46
−.01
−.16
−.002
.03
.17
−.01
.002

Constant

Age

Gender (0 = female)a

Disease type (0 = rectal)a

Years since treatment

Stoma status (0 = no stoma)a

Social function

Diarrhea

.002

.002

.12

.01

.11

.09

.01

.29

.09

−.43

.11

.15

−.001

−.14

−.10

.13

−.50

−.09

.06

−.02

−.12

.03

.30

.99

−4.44

1.36

1.83

−.01

−1.70

−1.12

1.40

−5.35

−1.14

.71

−.20

−1.56

t

.33

<.001

.18

.07

.99

.09

.27

.16

<.001

.26

.48

.85

.12

.77

Sig.

Dichotomozied variables with 0 indicating the reference group; categories included male/female for gender, rectal/anal for disease type, and stoma/no stoma for stoma status.

a

−.03

β

= 0.32)

.36

R2

SE

Anxiety model (F7,125 = 7.01, P < .001; R2 = 0.28)

−.17

Disease type (0 = rectal)

.002

Age

Gender (0 = female)

1.50

Constant

Depression Model (F7,125 = 8.45, P < .001;

B

Regression models supporting the mediating role of social functioning to explain the relationship between diarrhea and increased depression and anxiety
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